Inhibition of allergic response by intranasal selective NF-B decoy oligodeoxynucleotides in a murine model of allergic rhinitis
Limitations & Considerations The enrolled participants with obesity and overweight may represent a subpopulation with a greater commitment to weight-management efforts than the general population with obesity The measured baseline cardiometabolic risk factors in the trial population, such as blood pressure and lipids, were relatively normal, possibly attenuating the potential to show improvement, though meaningful changes in these variables were observed
For compounded semaglutide specifically, treatment duration considerations are similar, but access and cost dynamics differ
Understanding evidence-based strategies to support skin health, recognising when medical review is warranted, and maintaining realistic expectations can help patients optimise outcomes during treatment
One source says you need a prescription letter notarized in triplicate
Careful monitoring and dose adjustments may be necessary to mitigate this risk
